Federal State Autonomous Scientific Institution “Chumakov Federal Center for Research and Development of Immune‐and‐Biological Products of the Russian Academy of Sciences” (Institute of Poliomyelitis) (FSASI Chumakov FSC R&D IBP RAS [Institute of poliomyelitis]) Moscow Russia
Auto-generated profile, based on publicly available information
Olga Y. Baikova
Federal State Autonomous Scientific Institution “Chumakov Federal Center for Research and Development of Immune‐and‐Biological Products of the Russian Academy of Sciences” (Institute of Poliomyelitis) (FSASI Chumakov FSC R&D IBP RAS [Institute of poliomyelitis]) Moscow Russia
Introduction. The Global Polio Eradication Initiative strategy, along with vaccination and epidemiological surveillance efforts, includes measures to reduce the risk of poliovirus (PV) spread from laboratories and vaccine production facilities (containment). Due to containment requirements, studies to determine immunity to PV types 1–3 necessary for achieving program goals are limited for most laboratories, primarily for PV type 2. To replace the Sabin strains 1–3 typically used in the neutralization assay, genetically modified S19S strains 1–3 were developed. These strains retain the antigenic properties of the Sabin strains but exhibit a higher degree of attenuation and genetic stability. The objective of this study is to compare S19S strains 1–3 for use in the neutralization assay in cell culture to assess the levels of type-specific antibodies to PV types 1–3 and to determine the validation parameters for the method. Materials and methods. The study was conducted using the neutralization test in HEp2c cell using the standard WHO-recommended method at 36.5 °C for Sabin strains types 1–3 and at 33 °C for S19S strains types 1–3, using a set of reference sera and 50 sera from polio-vaccinated children. Results. Data from three independent experiments showed a high correlation between the neutralizing antibody titers obtained using S19S strains types 1–3 and the control Sabin strains types 1–3 (R 0.9). The repeatability and intermediate (intralaboratory) precision of the assay were also high (CV 10%). Conclusion. S19S strains 1–3 can be used as a replacement for Sabin strains 1–3 when performing a neutralization test in HEp2c cells to assess the level of type-specific antibodies to PV.